BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 19477652)

  • 1. Discovery, characterization and comparison of inhibitors of Bacillus anthracis and Staphylococcus aureus replicative DNA helicases.
    Aiello D; Barnes MH; Biswas EE; Biswas SB; Gu S; Williams JD; Bowlin TL; Moir DT
    Bioorg Med Chem; 2009 Jul; 17(13):4466-76. PubMed ID: 19477652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coumarin-based inhibitors of Bacillus anthracis and Staphylococcus aureus replicative DNA helicase: chemical optimization, biological evaluation, and antibacterial activities.
    Li B; Pai R; Di M; Aiello D; Barnes MH; Butler MM; Tashjian TF; Peet NP; Bowlin TL; Moir DT
    J Med Chem; 2012 Dec; 55(24):10896-908. PubMed ID: 23231076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimization of a novel potent and selective bacterial DNA helicase inhibitor scaffold from a high throughput screening hit.
    Li B; Pai R; Aiello D; Di M; Barnes MH; Peet NP; Bowlin TL; Moir DT
    Bioorg Med Chem Lett; 2013 Jun; 23(12):3481-6. PubMed ID: 23664213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of DNA gyrase and DNA topoisomerase IV of Staphylococcus aureus and Escherichia coli by aminocoumarin antibiotics.
    Alt S; Mitchenall LA; Maxwell A; Heide L
    J Antimicrob Chemother; 2011 Sep; 66(9):2061-9. PubMed ID: 21693461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacillus anthracis and Bacillus cereus PcrA helicases can support DNA unwinding and in vitro rolling-circle replication of plasmid pT181 of Staphylococcus aureus.
    Anand SP; Mitra P; Naqvi A; Khan SA
    J Bacteriol; 2004 Apr; 186(7):2195-9. PubMed ID: 15028705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ebselen and analogs as inhibitors of Bacillus anthracis thioredoxin reductase and bactericidal antibacterials targeting Bacillus species, Staphylococcus aureus and Mycobacterium tuberculosis.
    Gustafsson TN; Osman H; Werngren J; Hoffner S; Engman L; Holmgren A
    Biochim Biophys Acta; 2016 Jun; 1860(6):1265-71. PubMed ID: 26971857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screen for agents that induce autolysis in Bacillus subtilis.
    Lacriola CJ; Falk SP; Weisblum B
    Antimicrob Agents Chemother; 2013 Jan; 57(1):229-34. PubMed ID: 23089762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel semisynthetic derivative of antibiotic Eremomycin active against drug-resistant gram-positive pathogens including Bacillus anthracis.
    Maples KR; Wheeler C; Ip E; Plattner JJ; Chu D; Zhang YK; Preobrazhenskaya MN; Printsevskaya SS; Solovieva SE; Olsufyeva EN; Heine H; Lovchik J; Lyons CR
    J Med Chem; 2007 Jul; 50(15):3681-5. PubMed ID: 17608397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New aminocoumarin antibiotics as gyrase inhibitors.
    Heide L
    Int J Med Microbiol; 2014 Jan; 304(1):31-6. PubMed ID: 24079980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibacterial activity and mechanism of action of a novel anilinouracil-fluoroquinolone hybrid compound.
    Butler MM; Lamarr WA; Foster KA; Barnes MH; Skow DJ; Lyden PT; Kustigian LM; Zhi C; Brown NC; Wright GE; Bowlin TL
    Antimicrob Agents Chemother; 2007 Jan; 51(1):119-27. PubMed ID: 17074800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Baulamycins A and B, broad-spectrum antibiotics identified as inhibitors of siderophore biosynthesis in Staphylococcus aureus and Bacillus anthracis.
    Tripathi A; Schofield MM; Chlipala GE; Schultz PJ; Yim I; Newmister SA; Nusca TD; Scaglione JB; Hanna PC; Tamayo-Castillo G; Sherman DH
    J Am Chem Soc; 2014 Jan; 136(4):1579-86. PubMed ID: 24401083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virtual screening of LPXTG competitive SrtA inhibitors targeting signal transduction mechanism in Bacillus anthracis: a combined experimental and theoretical study.
    Selvaraj C; Sivakamavalli J; Baskaralingam V; Singh SK
    J Recept Signal Transduct Res; 2014 Jun; 34(3):221-32. PubMed ID: 24490975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical study of recombinant PcrA from Staphylococcus aureus for the development of screening assays.
    Dubaele S; Martin C; Bohn J; Chène P
    J Biochem Mol Biol; 2007 Jan; 40(1):7-14. PubMed ID: 17244476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acyl-sulfamates target the essential glycerol-phosphate acyltransferase (PlsY) in Gram-positive bacteria.
    Cherian PT; Yao J; Leonardi R; Maddox MM; Luna VA; Rock CO; Lee RE
    Bioorg Med Chem; 2012 Aug; 20(16):4985-94. PubMed ID: 22795901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-thiolated 2-oxazolidinones: a new family of antibacterial agents for methicillin-resistant Staphylococcus aureus and Bacillus anthracis.
    Mishra RK; Revell KD; Coates CM; Turos E; Dickey S; Lim DV
    Bioorg Med Chem Lett; 2006 Apr; 16(8):2081-3. PubMed ID: 16464583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanistic and Structural Basis for the Actions of the Antibacterial Gepotidacin against Staphylococcus aureus Gyrase.
    Gibson EG; Bax B; Chan PF; Osheroff N
    ACS Infect Dis; 2019 Apr; 5(4):570-581. PubMed ID: 30757898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triaminotriazine DNA helicase inhibitors with antibacterial activity.
    McKay GA; Reddy R; Arhin F; Belley A; Lehoux D; Moeck G; Sarmiento I; Parr TR; Gros P; Pelletier J; Far AR
    Bioorg Med Chem Lett; 2006 Mar; 16(5):1286-90. PubMed ID: 16343901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological activities of novel gyrase inhibitors of the aminocoumarin class.
    Anderle C; Stieger M; Burrell M; Reinelt S; Maxwell A; Page M; Heide L
    Antimicrob Agents Chemother; 2008 Jun; 52(6):1982-90. PubMed ID: 18347114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel 1,2,4-oxadiazole-chalcone/oxime hybrids as potential antibacterial DNA gyrase inhibitors: Design, synthesis, ADMET prediction and molecular docking study.
    Ibrahim TS; Almalki AJ; Moustafa AH; Allam RM; Abuo-Rahma GEA; El Subbagh HI; Mohamed MFA
    Bioorg Chem; 2021 Jun; 111():104885. PubMed ID: 33838559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of inhibitors of 4'-phosphopantetheine adenylyltransferase (PPAT) to validate PPAT as a target for antibacterial therapy.
    de Jonge BL; Walkup GK; Lahiri SD; Huynh H; Neckermann G; Utley L; Nash TJ; Brock J; San Martin M; Kutschke A; Johnstone M; Laganas V; Hajec L; Gu RF; Ni H; Chen B; Hutchings K; Holt E; McKinney D; Gao N; Livchak S; Thresher J
    Antimicrob Agents Chemother; 2013 Dec; 57(12):6005-15. PubMed ID: 24041904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.